Do current indices predict cardioversion success in patients with atrial fibrillation? A retrospective observational study

dc.contributor.authorSefa Tatar
dc.contributor.authorYunus Emre Yavuz
dc.contributor.authorEmirhan Feyzullahoglu
dc.contributor.authorAhmet Lütfi Sertdemir
dc.contributor.authorAbdullah Icli
dc.contributor.authorHakan Akilli
dc.date.accessioned2025-01-10T11:48:49Z
dc.date.available2025-01-10T11:48:49Z
dc.date.issued2024
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü
dc.description.abstractObjective: Atrial fibrillation (AF) is one of the leading arrhythmias that causes serious complications. Our aim is to investigate the factors predicting the success of cardioversion in patients who underwent the procedure due to AF. Methods: A total of 107 patients who underwent cardioversion were included in the study. Patients were divided into groups based on cardioversion success. Demographic, echocardiographic, and laboratory characteristics were compared between the groups. Results: Hypertension and diabetes mellitus were more frequent in patients with successful cardioversion, but no statistically significant difference was found between the groups (p > 0.05). The pre-procedure leukoglycemic index (LGI) was found to be higher in the successful cardioversion group. However, this difference was not statistically significant between the groups (p > 0.05). Although the fibrosis-4 (FIB-4) index and systemic immune-inflammation index (SII) were numerically higher in the group with unsuccessful cardioversion, no statistically significant difference was observed between the groups (p > 0.05). Echocardiographic parameters such as left atrial diameter and mitral regurgitation rate were higher in patients with successful cardioversion, but no significant difference was detected between the groups (p > 0.05). Conclusion: AF is a significant arrhythmia that may lead to high mortality and morbidity. Various scoring systems have been developed to predict cardioversion success. The LGI, FIB-4 index, and SII are potential predictors of cardioversion success. However, these parameters alone are insufficient to predict cardioversion success. Further large-scale randomized studies are needed to clarify the effectiveness of these parameters.
dc.identifier.citationTatar, S., Yavuz, Y. E., Feyzullahoglu, E., Sertdemir, A. L., Icli, A., & Akilli, H. Do current indices predict cardioversion success in patients with atrial fibrillation? A retrospective observational study.
dc.identifier.doi10.2478/rjc-2024-0028
dc.identifier.issn2734-6382
dc.identifier.scopus2-s2.0-85213386102
dc.identifier.scopusqualityQ4
dc.identifier.urihttps://doi.org/10.2478/rjc-2024-0028
dc.identifier.urihttps://hdl.handle.net/20.500.12604/8421
dc.indekslendigikaynakScopus
dc.institutionauthorYavuz, Yunus Emre
dc.publisherWalter de Gruyter GmbH
dc.relation.ispartofRomanian Journal of Cardiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAtrial fibrillation
dc.subjectcardioversion
dc.subjectfibrosis-4 index
dc.subjectleukoglycemic index
dc.subjectsystemic immune-inflammation index
dc.titleDo current indices predict cardioversion success in patients with atrial fibrillation? A retrospective observational study
dc.typejournal-article

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
yunus emre-yavuz-2024.pdf
Boyut:
5.4 MB
Biçim:
Adobe Portable Document Format
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: